Suppression of VEGFR-mediated angiogenesis can lead to hypovolemia, endothelial dysfunction, and impaired nitric oxide release, collectively resulting in vasomotor instability, myocardial ischemia, and hypotension. The gene discussed is KDR; the disease is endothelial dysfunction.